NCT01898130View on ClinicalTrials.gov

Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 27, 2013

Primary Completion Date

March 23, 2017

Study Completion Date

September 5, 2018

Conditions
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

bevacizumab

Given IV

PROCEDURE

quality-of-life assessment

Ancillary studies

Trial Locations (4)

10032

Columbia University Medical Center, New York

60045

Northwestern Memorial Hospital: Lake Forest Hospital, Lake Forest

60555

Cadence Health - CDH, Warrenville

60611

Northwestern University, Chicago

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Northwestern University

OTHER